| Particulars |
| Company Name |
Zydus Lifesciences Ltd |
| Face Value |
1 |
| BSE Code |
532321 |
| Year End |
202603 |
| Full Year |
| Equity (Rs in Cr.) |
99.75 |
| B.V. Rs |
237.30 |
| Sales Rs in Cr. |
11,486.40 |
| NP Rs in Cr. |
3,691.18 |
| NP Var% |
-36.00 |
| Div% |
100.00 |
| CPS Rs |
42.60 |
| EPS Rs |
37.00 |
| Traded Value(Rs in Lakhs) |
3,832.43 |
| 52 Week High |
1,249.00 |
| 52 Week Low |
836.00 |
| Price BSE |
1,244.00 |
| Price NSE |
1,246.00 |
| Market Capital(Rs in Cr.) |
124,089.48 |
| P/C Ratio |
29.20 |
| P/E Ratio |
33.60 |
| Price Vs.BV |
5.24 |
| Latest Quarter |
| Year End |
202606 |
| Sales Rs in Cr. |
2,723.50 |
| NP Rs in Cr. |
339.60 |
| NP Var % |
-12.00 |
| Trailing Twelve Months |
| Year End |
202606 |
| Sales |
11,945.40 |
| OPM |
48.07 |
| NP |
4,352.72 |
| NP Var% |
-18.25 |
| EPS |
36.54 |
| PE |
34.04 |
|